Prelude Therapeutics Incorporated Share Price
PRLDPrelude Therapeutics Incorporated Stock Performance
Open $4.67 | Prev. Close $4.65 | Circuit Range N/A |
Day Range $4.43 - $4.81 | Year Range $0.76 - $5.54 | Volume 18,982 |
Average Traded $4.57 |
Prelude Therapeutics Incorporated Share Price Chart
About Prelude Therapeutics Incorporated
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin-dependent kinase 9 inhibitor for the treatment of advanced solid tumors. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC, and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Prelude Therapeutics Incorporated Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-May-26 | $4.90 | $4.64 | -3.33% |
11-May-26 | $4.85 | $4.80 | -1.13% |
08-May-26 | $5.29 | $4.86 | -5.82% |
07-May-26 | $4.80 | $5.16 | +7.06% |
06-May-26 | $4.69 | $4.82 | +2.45% |
05-May-26 | $4.76 | $4.70 | -0.74% |
04-May-26 | $4.75 | $4.74 | +0.74% |
FAQs on Prelude Therapeutics Incorporated Share Price
Can I buy Prelude Therapeutics Incorporated shares in India?
What is the share price of Prelude Therapeutics Incorporated?
What is the 5 year returns of Prelude Therapeutics Incorporated?
What are the high & low stock price of Prelude Therapeutics Incorporated today?
What is the 52-week high and low of Prelude Therapeutics Incorporated stock?